PUBLISHER: Allied Market Research | PRODUCT CODE: 1414859
PUBLISHER: Allied Market Research | PRODUCT CODE: 1414859
According to a new report published by Allied Market Research, titled, "Non-invasive Aesthetic Treatment Market," The non-invasive aesthetic treatment market was valued at $15.5 billion in 2022, and is estimated to reach $37.5 billion by 2032, growing at a CAGR of 9.2% from 2023 to 2032.
Non-invasive aesthetic treatment encompasses a wide range of cosmetic procedures and therapies that enhance an individual's physical appearance and address various concerns without the need for surgical intervention. These treatments are designed to improve skin quality, reduce signs of aging, and enhance specific features, often with minimal discomfort, minimal to no downtime, and a lower risk of complications compared to invasive surgical options. Common non-invasive treatments include Botox injections, dermal fillers, laser therapy, chemical peels, and microdermabrasion, among others. These procedures typically target issues such as
1) wrinkles, fine lines, acne scars, skin texture irregularities, and volume loss. The non-invasive aesthetic treatment industry is characterized by ongoing advancements in technology and a growing demand driven by societal pressures and the pursuit of a more youthful and appealing appearance.
The rise in awareness about non-invasive aesthetic treatment procedures, as well as the increase in adoption of this procedure among the elderly and young population for enhancing their appearance, is driving the growth of the non-invasive aesthetic treatment market. For instance, according to the International Society of Aesthetic Plastic Surgeons (IASPS), the number of non-surgical fat reduction procedures performed on individuals under the age of 18 has been steadily increasing in recent years. In 2020, the ASPS reported that there were approximately 24,488 non-surgical fat reduction procedures performed on individuals under the age of 18, which represents a 3.4% of the total non-surgical fat reduction procedures.
In addition, technological advancements play a pivotal role in driving the growth of the non-invasive aesthetics market. These innovations have revolutionized the industry by making procedures safer, more effective, and appealing to a wider range of patients. One significant impact of technological advancements is the development of non-invasive alternatives to surgical procedures. For instance, the introduction of advanced laser technology has enabled a variety of skin resurfacing and resurfacing procedures, including laser hair removal, tattoo removal, and skin tightening. These treatments often have reduced downtime, lower risk, and offer more predictable outcomes than their surgical counterparts. In addition, these advances have allowed for more comfortable and painless procedures, further encouraging patients to consider non-invasive aesthetic treatments.
However, the non-invasive aesthetics market faces growth restraints, primarily due to high costs and inconsistent results. The expense of these treatments be prohibitive for many individuals, limiting their accessibility. Moreover, inconsistent outcomes, varying from person to person, lead to patient dissatisfaction. The combination of cost concerns and uncertain results deter potential clients and affect market expansion, making affordability and effectiveness crucial considerations for both providers and patients.
The non-invasive aesthetic treatment market is segmented on the basis of procedure, gender, age group, and end user and region. On the basis of procedure, the market is classified into injectables, skin resurfacing, and others. The injectables segment is further divided into neurotoxins, HA filler and non-HA fillers. The skin resurfacing segment is further divided into chemical peel, laser skin resurfacing, and microdermabrasion. The others segment is further bifurcated into laser hair removal, non-surgical fat reduction, sclerotherapy and others. On the basis gender, the market is categorized into female and male. On the basis age group, the market is segregated into 13 to 39, 40 to 54, 55 to 69, age 70 and over. On the basis of end user, market is fragmented into specialty & dermatology clinics, hospital, and others. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The major key players that operate in the global non-invasive aesthetic treatment market are Cynosure Inc Sisram Medical Ltd, Abbvie Inc, Lumenis Ltd., Candela Corporation, Fotona, HTM Eletronica MerzPharma., Cutera and Bausch Health Companies Inc.
Additional benefits you will get with this purchase are:
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)